Delta4 Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
11
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$4.27M
- Investors
-
2
Delta4 General Information
Description
Developer of an artificial intelligence-supported digital drug development platform designed to advance drug research. The company's proprietary platform integrates systems biology, computational modeling, artificial intelligence, and large-scale data, enabling pharmaceutical and biotechnology companies to understand disease mechanisms and accelerate drug development with greater precision.
Contact Information
Website
delta4.aiCorporate Office
- Alser Straße 23
- DG / Top 30
- Vienna, Vienna 1080
- Austria
Corporate Office
- Alser Straße 23
- DG / Top 30
- Vienna, Vienna 1080
- Austria
Delta4 Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC (Series A) | 07-Apr-2021 | $4.27M | Completed | Generating Revenue | ||
| 2. Accelerator/Incubator | Completed | Startup | ||||
| 1. Angel (individual) | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Delta4 Comparisons
Industry
Financing
Details
Delta4 Competitors (4)
One of Delta4’s 4 competitors is Healx, a Venture Capital-Backed company based in Cambridge, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Healx | Venture Capital-Backed | Cambridge, United Kingdom | ||||
| Biotx.ai | Venture Capital-Backed | Potsdam, Germany | ||||
| SOM Biotech | Venture Capital-Backed | Barcelona, Spain | ||||
| Pharnext | Formerly VC-backed | Paris, France |
Delta4 Patents
Delta4 Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4686474-A1 | Dpp-iv inhibitors for the treatment or prevention of autoimmune liver diseases | Pending | 31-Jul-2024 | ||
| WO-2024017844-A1 | Novel use of glucagon-like peptide 1 (glp-1) agonist | Inactive | 18-Jul-2022 | ||
| AU-2021393786-A1 | Clopidogrel for use in the treatment of focal segmental glomerulosclerosis (fsgs) | Inactive | 03-Dec-2020 | ||
| AU-2021393786-A9 | Clopidogrel for use in the treatment of focal segmental glomerulosclerosis (fsgs) | Inactive | 03-Dec-2020 | ||
| CA-3204074-A1 | Clopidogrel for use in the treatment of focal segmental glomerulosclerosis (fsgs) | Pending | 03-Dec-2020 | A61K45/06 |
Delta4 Signals
Delta4 Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| EU-India Innocenter | Accelerator/Incubator | |||
| Angel (individual) | Minority |
Delta4 FAQs
-
When was Delta4 founded?
Delta4 was founded in 2019.
-
Where is Delta4 headquartered?
Delta4 is headquartered in Vienna, Austria.
-
What is the size of Delta4?
Delta4 has 11 total employees.
-
What industry is Delta4 in?
Delta4’s primary industry is Drug Discovery.
-
Is Delta4 a private or public company?
Delta4 is a Private company.
-
What is the current valuation of Delta4?
The current valuation of Delta4 is .
-
What is Delta4’s current revenue?
The current revenue for Delta4 is .
-
How much funding has Delta4 raised over time?
Delta4 has raised $4.27M.
-
Who are Delta4’s investors?
EU-India Innocenter and have invested in Delta4.
-
Who are Delta4’s competitors?
Healx, Biotx.ai, SOM Biotech, and Pharnext are competitors of Delta4.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process